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Problem-solving courts were established in 1989 to provide 
an alternative to prison sentences or traditional 
probation/corrections supervision.1   Participants in most 
programs have serious substance abuse issues and have been 
charged with nonviolent offenses. Drug Court is unique 
because it represents a close working relationship between 
chemical dependency treatment and the criminal justice 
system. It is a highly structured program that combines 
intensive supervision, regular communication between 
participants and the team, and chemical dependency 
treatment/addiction recovery support. The program is 
committed to assisting with the early intervention, treatment 
and rehabilitation of offenders who are found to have 
substance use disorders.  
 
In 2009, there were 2,459 operational Drug Courts in the 
United States; Indiana and Minnesota have conducted their 
programs since 1996 and 2006, respectively.2 Drug Court 
provides a valuable and structured opportunity for those who 
wish to change the circumstances of their lives and break the 
cycle of addiction. A Drug Court Team is composed of 
professionals from public health, treatment and recovery, 
probation and parole, law enforcement, prosecutors, defense 
attorneys, a judge, and in some cases health and mental 
health providers that work together to support participants in 
the program.  While the majority of Drug Court participants 
are adults, there are problem-solving courts that focus on 
diverse populations such as Juvenile Drug Court, Veterans 
Drug Court, Reentry Drug Court, Family Drug Court, Tribal 
Drug Court, and Designated DWI Drug Court.1,3  
 
Reports have shown Drug Courts to be effective in reducing 
criminal recidivism, typically measured by re-arrests for new 
offenses and technical violations. Several meta-analyses have 
reported superior effects for these programs over 
randomized or matched comparison samples of drug 
offenders who were on probation or undergoing traditional 
criminal case processing.4,5,6,7 In each analysis, results 
revealed that Drug Courts significantly reduced re-arrest or 
reconviction rates by an average of approximately 8 to 26 
percent. 4,5,6,7 
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Drug Courts are also proven to be highly cost-effective.8 One 
cost-related meta-analysis concluded that Drug Courts 
produce an average of $2.21 in direct benefits to the criminal 
justice system for every $1.00 invested — a 221% return on 
investment.9 When services are targeted to the more serious, 
higher-risk offenders, the average return on investment was 
determined to be even higher at $3.36 in direct benefits for 
every $1.00 invested.9  These savings reflect a considerable 
cost-offset to the criminal justice system resulting from 
reduced re-arrests, law enforcement contacts, court hearings, 
and use of jail or prison beds.10 When more indirect cost-
offsets were also taken into account, including savings from 
reduced foster care placements and healthcare service 
utilization, studies have reported economic benefits ranging 
from approximately $2.00 to $27.00 for every $1.00 
invested.11 The result is net economic benefits to local 
communities ranging from approximately $3,000 to $13,000 
per Drug Court participant. 12,13,14 
 
Drug Court teams utilize a multidisciplinary approach that 
takes advantage of the expertise and skills of a variety of 
professionals.  The most effective programs require regular 
attendance by the judge, defense counsel, prosecutor, 
treatment providers and law enforcement officers at staff 
meetings or status hearings.15 Although able to provide 
valuable services to the team and participants, pharmacists 
are not often working with Drug Courts and their role and 
contributions on the Drug Court Team are areas for further 
development and research. 
 
At Purdue University College of Pharmacy (PUCOP) and the 
University of Minnesota – College of Pharmacy (UMCOP), 
pharmacists have been a part of local Drug Court teams for a 
number of years. As a team member, the pharmacist is an 
integral part of the interdisciplinary and multi-agency team 
that seeks to support participants who are working to break 
the cycle of addiction and recreate their lives. The pharmacist 
is well trained to act as Health Care Advocate, support the 
participants on health-related situations, ensure that their 
patient rights are addressed, and medical attention is 
provided when needed.  
 
In June 2004, Tippecanoe County in Indiana developed the 
Tippecanoe County Forensic Diversion Program (FDP) through 
federal funding. Adult Drug Court (ADC) was already in 
existence through certification from the Indiana Judicial 
Center. One of the co-authors was asked to join the FDP and 
ADC teams in October 2004 to provide a health care 
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perspective and approach to the programs’ goals. Since 2005 
and currently, the PUCOP provides service as Health Care 
Advocates and PharmD candidates elect to complete a four-
week Advanced Pharmacy Practice Experience in Community 
Corrections. To date, there have been over 220 Purdue 
student pharmacists who have participated in the rotation. 
 
Problem-solving courts at Tippecanoe County and Carlton 
County are similar although they serve very different 
populations. Tippecanoe County participants are nonviolent 
felons with substance abuse and mental illness (dual 
diagnosis), whereas in Carlton County, the participants are 
also nonviolent individuals who may or may not have mental 
illness. Carlton County participants must have a felony drug 
possession or sales charge, property crime charge such as 
financial card transaction fraud, check fraud, criminal damage 
to property or burglary.   Participants have had a rule 25 
assessment that indicates that they have substance use 
disorder that is at least mild or severe, and they need to have 
a high risk score on the risk assessment tool called the Level 
of Services / Case Management Index (LS/CMI). The Carlton 
County Drug Court is unique in that it is composed of a 
partnership between Carlton County and the Fond du Lac 
Band of Lake Superior Chippewa. At both Drug Court sites, 
pharmacists and pharmacy students attend weekly Drug 
Court team meetings to discuss the progress of participants, 
with a special focus on health-related needs. The pharmacist 
meets individually with selected participants before and/or 
after court sessions, communicates with the participants’ 
provider(s) as needed regarding the participants’ treatment 
plans, and acts as a liaison with other health providers and as 
a patient advocate. When appropriate, the pharmacist 
provides direct treatment services such as medication 
counseling, medical referrals, and appropriate self-care 
approaches.  Other pharmacy services include smoking 
cessation, nutrition education, physical activity counseling, 
and use of dietary supplements and over-the-counter 
medications. The pharmacist maintains personal and 
telephone communication with participants when 
appropriate, and joins participants and other team members 
at pro-social events outside of court, including 5K runs, 
sporting events, sobriety feasts, and other celebrations. The 
Purdue Health Care Advocates accompany participants to 
health-related appointments, monitor opioid medication use 
when appropriate, and are also responsible for phase move 
and exit interviews with participants. All interactions with 
participants are professionally documented and are 
maintained in individual participant files. 
 
The Drug Court pharmacist serves as a critical link between 
the Drug Court team, the University, and other community 
agencies. Pharmacy students – and other pharmacists – who 
participate in Drug Court are able to learn from the process 
and gain a more personal view of addiction and corrections. 
The Drug Court pharmacist at the University of Minnesota is 
active on the local Drug Abuse Task Force and has worked as 
a part of a local team to plan a Community Forum on Heroin 
and Opioid Abuse, as well as monthly educational events 
following the Forum. This has led to numerous opportunities 
for the pharmacist and pharmacy students to engage with 
public health efforts across greater Minnesota with several 
counties and Tribal Nations. The Purdue pharmacist has 
presented at local, state, and national meetings of drug court 
professionals to educate on the role of pharmacists in Drug 
Courts. 
 
A practice in Drug Court is feasible for pharmacists in many 
different practice settings, including academia, community 
pharmacy, ambulatory care pharmacy and institutional 
pharmacy. Participation on a local Drug Court team as a 
consultant could include as a few as two hours of a 
pharmacists time; a more engaged practice could require 
eight or more hours of time per week.   Drug Court 
pharmacists regularly attend pre-court team meetings to 
review participant progress, have a vote on appropriate 
actions to improve outcomes, and prepare for status hearings 
in court. It is in the pre-court staff meetings that the 
pharmacist is able to consult with other team members to 
provide drug information and give updates on the 
pharmaceutical and health status of Drug Court participants. 
A 2012 study by Green and Rempel showed that 
approximately one-quarter of Drug Court participants suffer 
from chronic medical or dental conditions that cause them 
serious discomfort, require ongoing medical attention, or 
interfere with their daily functioning. 16 Ensuring that 
participants are provided with proper medical or dental 
treatment may improve their likelihood of success in the Drug 
Court Program;17  the pharmacist is well-suited to provide 
care coordination and to serve as a medical home for the 
Drug Court participant.  Clinical interventions may relate to 
providing information for medically assisted treatment 
options such as Suboxone or methadone, pharmaceutical 
care for acute situations (emergency room visits), chronic 
disease states such as diabetes, hypertension, and heart 
failure, and guidance seeking treatment for mental health 
concerns including depression and anxiety.  The pharmacist 
has a unique and valuable skillset to bring to Drug Court and 
has the potential to improve participant health outcomes and 
Drug Court graduation rates.   
 
Drug Courts have been shown to reduce crime in participants 
and graduates, save the criminal justice and health care 
systems money, reduce victimization, and restore families. 
Many Drug Court teams struggle to meet the health care 
needs of their participants because there often is no health 
care provider or mental health provider on the team. The role 
of the pharmacist on the Drug Court team deserves 
exploration in light of the increasing needs of problem-solving 
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courts across the United States and the current substance 
abuse epidemic that unfortunately includes prescription 
drugs.  As the profession of pharmacy seeks to expand 
practice to meet the needs of community and public health, 
Drug Court is a logical and necessary practice to invest in. 
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